Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer

Chemo-radiotherapy (CRT) remains the main treatment modality for non-small-cell lung cancer (NSCLC). However, its clinical efficacy is largely limited by individual variations in radio-sensitivity and radiotherapy-associated toxicity. There is an urgent need to identify genetic determinants that can...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Kewen, Zhang, Shaotong, Pang, Jiaohui, Yin, Jiani C., Mu, Dianbin, Wang, Jun, Ge, Hong, Ma, Jie, Yang, Zhe, Zheng, Xiaoli, Dong, Lihua, Zhang, Junli, Chang, Pengyu, Li, Li, Tang, Shanshan, Bao, Hua, Wu, Xue, Wang, Xiaonan, Shao, Yang, Yu, Jinming, Yuan, Shuanghu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329611/
https://www.ncbi.nlm.nih.gov/pubmed/35912186
http://dx.doi.org/10.3389/fonc.2022.928605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329611/
https://www.ncbi.nlm.nih.gov/pubmed/35912186
http://dx.doi.org/10.3389/fonc.2022.928605

Ejemplares similares